U.S. FDA approves Parkinson’s treatment from Sunovion Pharma
(Reuters) – The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon Pharma , for the treatment of “off” episodes...
Read More